BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26016451)

  • 1. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.
    Kotur-Stevuljevic J; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Stefanovic A; Gojkovic T; Joksic J; Sopic M; Gulan B; Janac J; Milosevic S
    Atherosclerosis; 2015 Jul; 241(1):192-8. PubMed ID: 26016451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Paraoxonase 1 Activity and Oxidative/Antioxidative Stress Markers in Patients with Acute Cerebral Infarction.
    Zhu H; Zhao T; Liu J
    Clin Lab; 2018 Jun; 64(6):1049-1053. PubMed ID: 29945323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
    Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
    Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
    Kim NS; Kang K; Cha MH; Kang BJ; Moon J; Kang BK; Yu BC; Kim YS; Choi SM; Bang OS
    Biochem Biophys Res Commun; 2007 Dec; 364(1):157-62. PubMed ID: 17936248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows.
    Turk R; Juretić D; Geres D; Svetina A; Turk N; Flegar-Mestrić Z
    Anim Reprod Sci; 2008 Oct; 108(1-2):98-106. PubMed ID: 17850995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: A case report.
    Kuburovic V; Vekic J; Zeljkovic A; Carrie A; Kotur-Stevuljevic J; Bojanin D; Kosutic J; Spasojevic-Kalimanovska V; Miljkovic M; Kuburovic N; Couvert P
    Clin Biochem; 2017 Dec; 50(18):1323-1325. PubMed ID: 28648695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.
    Agouridis AP; Tsimihodimos V; Filippatos TD; Dimitriou AA; Tellis CC; Elisaf MS; Mikhailidis DP; Tselepis AD
    Expert Opin Pharmacother; 2011 Dec; 12(17):2605-11. PubMed ID: 21714585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.
    Kuwashiro T; Sugimori H; Kamouchi M; Ago T; Kitazono T; Iida M
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):561-8. PubMed ID: 21376631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.